Cannara Biotech Announces Expansion of Phase 1 Build-Out

Published: March 15, 2019

Cannara Biotech Announces Expansion of Phase 1 Build-Out

Cannara Biotech Inc., a vertically integrated cannabis company in the making focused on cultivation and cannabis-infused products, today announced an expansion of the Phase 1 build-out of Cannara’s facility from 130,000 to 170,000 square feet. As a result, the license application at Cannara’s Farnham location, in process with Health Canada, has been modified accordingly. The 40 000-square-foot expansion will provide more flexibility for cultivation and post-harvest operations. The timelines to complete Phase 1 construction of Cannara’s facility have not been affected by the expansion.

Separately, Besar Xhelili has resigned from the Company’s Board of Directors to pursue other business interests. The Company is actively evaluating alternative independent directors and expects to fill the vacancy in a timely fashion.

“We are grateful to Besar for his contributions to Cannara and wish him all the best in his future endeavours,” said Zohar Krivorot, President and CEO of Cannara Biotech.

Recent News

View All News Items

Latest Article

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

At any step in the cannabis supply chain, your labeling system should allow for full control and traceability, from seed to sale. Implementing lean principles and labeling best practices across the cannabis supply chain can help you streamline your seed-to-sale labeling process and help you gain control.

Click below to read the full blog and learn how to reduce waste, cut costs, and gain efficiency with cannabis labeling: https://bit.ly/2KwZ5IQ

Read Article